Immunological data of patients
. | Ig levels (g/liter) . | . | . | . | . | . | . | . | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | IgM . | IgG . | IgG1 . | IgG2 . | IgG3 . | IgG4 . | IgA . | CD27+/CD19+ (%)a . | ||||||
P1b (9 yr) | 2.5b | 3.5b | ND | ND | ND | ND | <0.06b | 4 | ||||||
P2 (22 yr) | 1 | 7.4 | 4.6 | 0.3 | 0.4 | 0.002 | 2.6 | 6 | ||||||
P3 (9 yr) | 0.8 | 8.7 | ND | ND | ND | ND | 0.3 | ND | ||||||
P3 (17 yr) | 2.5 | 8.9 | 6.2 | 0.1 | 0.3 | 0.001 | 0.8 | 23 | ||||||
Controls (9 yr) | 0.5–1.5 | 5.8–11.5 | 0.5–1.6 | 13–58 | ||||||||||
Controls (17–22 yr) | 0.5–2.1 | 6.6–12.7 | >4 | >0.6 | >0.2 | >0.01 | 0.7–3.4 | 13–58 |
. | Ig levels (g/liter) . | . | . | . | . | . | . | . | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | IgM . | IgG . | IgG1 . | IgG2 . | IgG3 . | IgG4 . | IgA . | CD27+/CD19+ (%)a . | ||||||
P1b (9 yr) | 2.5b | 3.5b | ND | ND | ND | ND | <0.06b | 4 | ||||||
P2 (22 yr) | 1 | 7.4 | 4.6 | 0.3 | 0.4 | 0.002 | 2.6 | 6 | ||||||
P3 (9 yr) | 0.8 | 8.7 | ND | ND | ND | ND | 0.3 | ND | ||||||
P3 (17 yr) | 2.5 | 8.9 | 6.2 | 0.1 | 0.3 | 0.001 | 0.8 | 23 | ||||||
Controls (9 yr) | 0.5–1.5 | 5.8–11.5 | 0.5–1.6 | 13–58 | ||||||||||
Controls (17–22 yr) | 0.5–2.1 | 6.6–12.7 | >4 | >0.6 | >0.2 | >0.01 | 0.7–3.4 | 13–58 |